Lassa Fever in West Africa: The Emerging Role of Aerial Logistics in Epidemic Response

References

[1] Achigan, D., Codjia, J., & Bokonon-Ganta, A. (2003). Dynamics and reproductive biology of cropland small rodents in Southern Benin and effect of climatic factors on the population dynamics. In R. H. Makundi (Ed.), Abstracts of the 9th international african small mammal symposium. Morogoro, Tanzania: Sokoine University of Agriculture.

[2] Aigbiremolen, A., Ireye, F., Anderson, D., Hsieh, S., Robinson, J., & Asogun, D. (2023).

[3] Demographic and housing factors in Lassa fever transmission in a high disease burden State in Nigeria. Population Medicine, 5(Supplement), A247. doi:10.18332/popmed/165320.

[4] Ajayi, N., Nwigwe, C., & Azuogu, B. E. (2013). Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January-March 2012). Int J Infect Dis. , 17, 0–6. doi:10.1016/j.ijid.2013.05.015.

[5] Alli, A., Ortiz, J., Fabara, S., Patel, A., & Halan, T. (2021). Management of Lassa Fever: A Current Update. Cureus, 13(5), e14797. doi:10.7759/cureus.14797.

[6] Al-Mustapha, A., Adesiyan, I., Orum, T., Ogundijo, O., Lawal, A., Nzedibe, O., & al, e. (2025).

[7] Impact of Seasonal Changes on the Epidemiology of LassaFever in a State in North Central, Nigeria. Research Square, PREPRINT (Version 1). doi:10.21203/rs.3.rs-7638265/v1.

[8] Asogun, D., Arogundade, B., Unuabonah, F., Olugbenro, O., Asogun, J., Aluede, F., & Ehichioya, D. (2025). Review of the Epidemiology of Lassa Fever in Nigeria. Microorganisms, 13(6), 1419. doi:10.3390/microorganisms13061419.

[9] Bakke, H., Samdal, H., Holst, J., Oftung, F., Haugen, I., & Kristoffersen, A. (2006). Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity. Scand J Immunol., 63(3), 223–31.

[10] Balogun, O., Akande, O., & Hamer, D. (2020). Lassa Fever: An Evolving Emergency in West Africa. Am J Trop Med Hyg., 104(2), 466-473. doi:10.4269/ajtmh.20-0487.

[11] Besson, M., Pépin, M., & Metral, P. (2024). Lassa Fever: Critical Review and Prospects for Control. Trop Med Infect Dis., 9(8), 178. doi:10.3390/tropicalmed9080178.

[12] Bu, D., Hernandez, M., Haruna, F., Abasi, P. M., & Kremer, P. (2023). Improving Health Access Through the Distribution of COVID-19 Vaccines Using Drones in Ghana. Available at SSRN: https://ssrn.com/abstract=4401693.

[13] Buba, M. D., & Nguku, P. E. (2018). Mortality among confirmed Lassa fever cases during the 2015-2016 outbreak in Nigeria. Am J Public Health, 108, 262–264. doi:10.2105/AJPH.2017.304186.

[14] Dan-Nwafor, C., Furuse, Y., Ilori, E., Ipadeola, O., Akabike, K., Ahumibe, A., & Ukponu, W.(2019). Measures to control protracted large Lassa fever outbreak in Nigeria,. Euro Surveill., 24(20), 1900272. doi:10.2807/1560-7917.ES.2019.24.20.1900272.

[15] Douno, M., Asampong, E., Magassouba, N., Fichet-Calvet, E., & Almudena, M. (2021). Hunting and consumption of rodents by children in the Lassa fever endemic area of Faranah, Guinea. PLoS Negl. Trop Dis., 15, e0009212.

[16] Eneh, S., Obi, C., Ephraim, I. U., Dauda, Z., Udoewah, S., Anokwuru, C., Chizoba, A. (2025). The resurgence of Lassa fever in Nigeria: economic impact, challenges, and strategic public health interventions. Front Public Health, 13, 1574459. doi:10.3389/fpubh.2025.1574459.

[17] Ezenwa-Ahanene, A., Salawu, A., & Adebowale, A. (2024). Descriptive epidemiology of Lassa fever, its trend, seasonality, and mortality predictors in Ebonyi State, South- East, Nigeria, 2018-2022. BMC Public Health. 2024 Dec 18. doi: 10.1186/s12889-024-20840, 24(1), 3470. doi:10.1186/s12889-024-20840-y.

[18] Fichet-Calvet, E., & Rogers, D. (2009). Risk maps of Lassa fever in West Africa. PLoS Negl Trop Dis. , 3(3), e388. doi:10.1371/journal.pntd.0000388.

[19] Fisher-Hoch, S., Gborie, S., Parker, L., & Huggins, J. (1992). Unexpected adverse reactions during a clinical trial in rural West Africa. Antiviral Res., 19, 139–147. doi:10.1016/0166-3542(92)90073-e.

[20] Frame, J., Verbrugge, G., Gill, R., & Pinneo, L. (1984). The use of Lassa fever convalescent plasma in Nigeria. Trans R Soc Trop Med Hyg. , 78, 319–324. doi:10.1016/0035-9203(84)90107-x.

[21] Garry, R. (2023). Lassa fever - the road ahead. Nat Rev Microbiol, 87–96. doi:10.1038/s41579-022-00789-8.

[22] John-Ugwuanya A., Ifunanya J., Udensi, N. (2021). Epidemiological trends of Lassa fever in Nigeria from 2015-2021: A review. Ther Adv Infect Dis. , 8, 20499361211058252. doi:10.1177/20499361211058252.

[23] Haas, W., Breuer, T., & Pfaff, G. (2003). Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis., 36, 1254–1258. doi:10.1086/374853.

[24] Happi, A., & Happi, C. S. (2019). Lassa fever diagnostics: Past, present, and future. Current Opinion in Virology, 37, 132–138. https://doi.org/. doi:10.1016/j.coviro.2019.08.002 .

[25] Hulseberg, C., Fénéant, L., & Szymańska-de, W. K. (2019). Arbidol and other

[26] low-molecular-weight drugs that inhibit Lassa and Ebola viruses. J Virol. , 3, 2185–2118. doi:10.1128/JVI.02185-18.

[27] Ilori, E., Furuse, Y., & Ipadeola, O. (2019). Epidemiologic and clinical features of Lassa fever outbreak in Nigeria, January 1-May 6, 2018. Emerg Infect Dis. , 1066–1074. doi:10.3201/eid2506.181035.

[28] Isiguzo, G. C., & Iroezindu, M. O. (2019). Epidemiology and management of Lassa fever in the West African sub-region: Overcoming the socio-cultural challenges. In G. B. Tangwa et al. (Eds.), Socio-cultural dimensions of emerging infectious diseases in Africa (pp.41–55). Springer Nature Switzerland. https://doi.org/10.1007/978-3-030-17474-3_4

[29] Knoblauch, A., de la Rosa, S., Sherman, J., Blauvelt, C., Matemba, C., Maxim, L., Grandjean, L.

[30] S. (2019). Bi-directional drones to strengthen healthcare provision: experiences and lessons from Madagascar, Malawi and Senegal. BMJ Glob Health, 4(4), e001541. doi:10.1136/bmjgh-2019-001541.

[31] Kremer, P., Leyzerovskaya, A., DuBois, S., Lipsitt, J., Haruna, F., & Lebed, O. (2023). Bringing underserved communities life-saving aid through aerial logistics. Sci Robot. , 8(85), eadm7020. doi:10.1126/scirobotics.adm7020.

[32] Kumoji, K., Bride, M., Dickenson, T., Clayton, S., Nyuma, G., & Anschel-Brown, A. (2022). Environmental and behavioral determinants of Lassa fever: A qualitative exploration among communities and health care workers in Tonkolili and Kenema Districts, Sierra Leone. Baltimore: Johns Hopkins Center for Communication Programs.

[33] Lammers, D., Williams, J., Conner, J., Baird, E., Rokayak, O., McClellan, J., . . . Eckert, M. (2023). Airborne! UAV delivery of blood products and medical logistics for combat zones. Transfusion, 63(Suppl 3), S96-S104. doi:10.1111/trf.17329.

[34] Leirs, H., Verhagen, R., Verheyen, W., Mwanjabe, P., & Mbise, T. (1996). Forecasting rodent outbreaks in Africa: an ecological basis for Mastomys control in Tanzania. J. Appl. Ecol., 33, 937–943.

[35] Mandi H, A. D., Menon, S., Ndiaye, A., Ndifon, M., Nsaibirni, R., Ntiri, M., . . . Okogbenin, S.

[36] e. (2025). Prospective cohort study to evaluate Lassa fever incidence, symptoms and coinfection with malaria in West Africa: the Enable Lassa Research Programme (‘ENABLE 1.5’) – study protocol. BMJ Public Health, 3(2), e001960. doi:10.1136/bmjph-2024-001960.

[37] McCormick, J., King, I., & Webb, P. (1986). Lassa fever. Effective therapy with ribavirin. N Engl J Med., 314, 20–26. doi:10.1056/NEJM198601023140104.

[38] Mechan, F. B., Malone, D., & Lees, R. (2023). Unmanned aerial vehicles for surveillance and control of vectors of malaria and other vector-borne diseases. Malar J. , 22(1), 23. doi:10.1186/s12936-022-04414-0.

[39] Nyaaba, A. A., & Ayamga, M. (2021). Intricacies of medical drones in healthcare delivery: Implications for Africa. Technology in Society, 66( August 2021), 101624. doi:10.1016/j.techsoc.2021.101624.

[40] Ogundele, G., Jolayemi, K., & Bello, S. (2025). Lassa fever in West Africa: a systematic review and meta-analysis of attack rates, case fatality rates and risk factors. BMC Public Health, 25(1). doi:10.1186/s12889-025-24377-6.

[41] Olasoju, T., Olasoju, M., Dagash, B., Abaye, B., Enumah, C., Isah, S. B., & Adebowale, O. (2024). LASSA Fever in Internally-Displaced Persons' Camp: A Case Report at Zabarmari, Borno State, Nigeria. Ann Ib Postgrad Med., 22(1), 94-99.

[42] Olayinka, A., Elimian, K., Ipadeola, O., Dan-Nwafor, C., Gibson, J., Ochu, C., Namara, G. (2022). Analysis of sociodemographic and clinical factors associated with Lassa fever disease and mortality in Nigeria. PLOS Glob Public Health, 2(8), e0000191. doi:10.1371/journal.pgph.0000191.

[43] Ölschläger, S., Neyts, J., & Günther, S. (2011). Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus. Antiviral Res., 91, 89–93. doi:10.1016/j.antiviral.2011.05.006.

[44] Omobowale, O., Koski, A., Olaniyan, H., Nelson, B., Egbokhare, O., & Omigbodun, O. (2024). Effective community entry: reflections on community engagement in culturally sensitive research in southwestern Nigeria. BMJ Glob Health, 9(9), e015068. doi:10.1136/bmjgh-2024-015068.

[45] Qing, Y., Hui, L., & Ning, X. (2018). Unmanned aerial vehicles: potential tools for use in zoonosis control. Infectious Diseases of Poverty, 7(3), 66-71. doi:10.1186/s40249-018-0430-7.

[46] Raabe, V., Kann, G., & Ribner, B.(2017). Favipiravir and ribavirin treatment of epidemiologically linked cases of Lassa fever. Clin Infect Dis., 65, 855–859. doi:10.1093/cid/cix406.

[47] Redding, D., Gibb, R., & Dan-Nwafor, C. (2021). Geographical drivers and climate-linked dynamics of Lassa fever in Nigeria. . Nat Commun , 12, 5759. doi:10.1038/s41467-021-25910-y.

[48] Safronetz, D., Sogoba, N., Maiga, O., Dahlstrom, E., & Zivcec, M. (2013). Geographic distribution and genetic characterization of Lassa virus in sub-Saharan Mali. PLoS neglected tropical diseases, 7(12), e2582.

[49] Schmitz, H., Köhler, B., & Laue, T.. (2002). Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect., 4, 43–50. doi:10.1016/s1286-4579(01)01508-8.

[50] Shaffer, J., Grant, D., & Schieffelin, J. (2014). Lassa fever in post-conflict Sierra Leone. PLoS Negl Trop Dis, 8. doi:10.1371/journal.pntd.0002748.

[51] Singh, A., Mohandes, S., Muhodir, S., Zhang, W., Antwi-Afari, M., & Shakor, P. (2025).Exploring Barriers to Unmanned Aerial Vehicle (UAV) Technology for Construction Safety Management Using Mixed-Methods Approach. Buildings. 2025; 15(12):2092. https://doi.org/10.3390/bui, 15(12), 2092. doi:10.3390/buildings15122092.

[52] Uppala, P., Karanam, S., Kandra, N., & Edhi, S. (2025). Lassa fever: A comprehensive review of virology, clinical management, and global health implications. World J Virol., 14(3), 108405. doi:10.5501/wjv.v14.i3.108405.

[53] Wiley, M. R., Lawrence, S. F., Letizia, A. G., & al., e. (2019). Lassa virus circulating in Liberia: a retrospective genomic characterisation. The Lancet Infectious Diseases, 19(12), 1371 - 1378.

[54] World Health Organization. (2023, December 7). Lassa Fever—Nigeria. 2023. Retrieved 2025, from WHO Disease Outbreak News.: https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON463.

[55] Yessinou, R., Waladjo, A., Noudeke, N., Dramou, I., Adinsi, J., Dougnon, V., . . . Dansou, A. a. (2020). Dynamic and epidemiology of Lassa fever infection in west Africa’s population from 1969 to 2019. Hosts and Viruses, 7(6), 137-146. doi:10.17582/journal.hv/2020/7.6.137.146.

[56] Yun, N. E., & Walker, D. (2012). Pathogenesis of Lassa Fever. Viruses, 4(10), 2031–2048. doi:10.3390/v4102031.

[57] Zhang, X., Tang, K., & Guo, Y. (2020). The antifungal isavuconazole inhibits the entry of Lassa virus by targeting the stable signal peptide-GP2 subunit interface of Lassa virus glycoprotein. Antiviral Res., 174, 104701. doi:10.1016/j.antiviral.2019.104701.

@article{1713879,
      author = {Zakari Isiaka Osheku, Ndifreke Goddey Udoidung, Aisha Hassan Tukura; Amina Na?iya Aminu; Ilyas Bashir Usman, Hafsah Shuaib Muhammad; Sherifat Tolulope Akindele; Emmanuel Pius Oiwoh, Nuhu Momoh Abdullahi; Omobolanle Esther Fatona; Sumayya Usman Abdullahi},
      title = {Lassa Fever in West Africa: The Emerging Role of Aerial Logistics in Epidemic Response},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {9},
      number = {7},
      pages = {2398-2411},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1713879.pdf},
      abstract = {Lassa fever remains one of the most significant and persistent viral hemorrhagic fevers in West Africa. Despite over five decades of research and the availability of ribavirin, an antiviral with proven benefit when administered early, case fatality remains unacceptably high. The disease continues to expand geographically, with outbreaks becoming larger and more frequent. These challenges are compounded by limited diagnostic capacity, slow sample transport, and weak health systems. This review synthesizes evidence on the epidemiological transitions and control strategies for Lassa fever across West Africa from 2000–2024, emphasizing the emerging role of aerial logistics such as unmanned aerial vehicles (UAVs) or drones in epidemic preparedness, diagnostics, and supply-chain innovation. A narrative review approach was adopted. Peer-reviewed articles and grey literature published between 2000 and 2024 were retrieved from PubMed, Scopus, Web of Science, WHO, AJOL and Africa CDC repositories. Data were thematically synthesized under three domains: epidemiological transitions, control and prevention strategies, and innovations in epidemic logistics. Evidence indicates increasing incidence, expanding endemic range, and persistent high case fatality across West Africa. Epidemiological transitions are driven by ecological changes, urbanization, improved surveillance and socio-economic vulnerabilities. Control strategies, spanning surveillance, therapeutics, community engagement and one health approaches, have yielded mixed success due to deep systemic constraints. Emerging technologies such as drone-based logistics demonstrate transformative potential in reducing diagnostic delays, improving access to life-saving therapeutics, and strengthening resilience of epidemic response systems. Lassa fever remains a growing challenge in West Africa, requiring enhanced, technology-integrated epidemic management. The integration of aerial logistics systems into national surveillance and response frameworks represents a promising frontier for accelerating diagnosis, treatment and public health interventions. Greater investment in genomics, vaccine research, health systems strengthening, and logistics innovation is urgently needed to mitigate the long-term burden of this re-emerging threat.},
      keywords = {Lassa Fever, Epidemiology, West Africa, Control Strategies, Unmanned Aerial Vehicles, Drones, Aerial Logistics.},
      month = {January},
      doi = {https://doi.org/10.64388/IREV9I7-1713879}
  }